MDAI

magicjohnson89

MDAI will help those burns…metaphorically and literally

stockratic

I am very aware of MDAI. I disagree. As I state in the post, depression and suicidality are on the national crisis list for the FDA and are a priority for the military. The PR talks about the fame changer this drug showed to be in the prior trial and will be if successful in this upcoming trial.

PristineDiscount3208

MDAI - burn and wound care, also easy cross for diabetics

Consistent_Panda5891

After turning 200k into 440K I am now heavy invested in short time duration high yield bonds with about 7% average performance(less 3.5y yield). It dragged slightly this year due to bonds increase, so is a good time to buy. With state bonds increasing most likely it will return 8% next year. Also slightly invested in low market cap stock such as MDAI(30k), but because I like to support small businesses and honestly seems pretty undervalued. But so far biggest win ever was rolls Royce, did 10x after launching new gen of planes

vinkulafu

I hope AUR and OPEN will at least 10x over the next 5-10 years. Started below $5 so penny stocks but averaged up on AUR to just over $5 now. My other penny stocks are red - QNC, MDAI, OPEN.

Different_Hearing_55

MDAI

magicjohnson89

Blackie is right. I am not cut out for this at all. I don’t have that much money left now so I’m all in on MDAI. 9000 shares. That’s it. App deleted. Hopefully it works out. If it doesn’t I don’t actually care. What’s another £10k when you’ve blown over 50. If it hits 8 I’ll have broken even. Godspeed regards, I was the worst of you, and the even worst of you. Peace out.

magicjohnson89

More insider buying at MDAI. https://www.stocktitan.net/sec-filings/MDAI/form-4-spectral-ai-inc-insider-trading-activity-67e7228a84ac.html

magicjohnson89

What’s the price target? I chucked a grand in because it sounds like MDAI.

magicjohnson89

MDAI is making moves on low volume as well. Lowered my average to 2.17. I feel an imminent announcement of a sale (of their product).

magicjohnson89

MDAI earnings call in a couple hours. Watch it drop 20%.

IndividualCost8340

$MDAI. ..Use Grok or any AI. This company has a new revolutionary medical device. Search it yourself. Burn victims. Doctor's no longer guess in what skin cells can be saved. $10 stock. Just received FDA tentative approve and BARDA JUST IN VESTED MILLIONS.Thinj injured soldiers worldwide. Scale

magicjohnson89

Both the stocks I hold have earnings next week. MDAI 11th EVTL 13th Considering I'm already -25% and -40% for the love of god please be positive.

magicjohnson89

If MDAI was anything to go by sell the news lol

magicjohnson89

No am I fuck. That's another one of the worst stocks I've ever held. Complete grift and glad VW are about to go bankrupt. My fetish for pre-revenue bets is by no means over though. 50/50 between MDAI and EVTL.

magicjohnson89

I'm still resolutely holding MDAI and EVTL. I averaged down a fair bit. Currently -25% on both. Hold about 6000 shares in each of them. I haven't learnt any lessons and no I'm not selling anything for an ETF. We ball.

magicjohnson89

EVTL and MDAI settled and climbing now. Went from -45% to -28% on both, they've moved pretty much identically which is weird.

Fearless_Mojo

SLS … … (big gap) … DVLT … MDAI

Stitch426

Don’t bother with Nasdaq stocks under $1. It’s really just not worth the stress of a potential RS. Even announcing a vote for potential RS leads to a sell off. The deficiency notice leads to a down day. As the time runs out for compliance, the sell off ramps up. The company can have a RS already approved by shareholders and later on they send a letter to Nasdaq to have a RS done with you only getting 2 days notice. And then…. You guessed it.., it sells off. If you’re busy with life, in the hospital, have a power outage, have issues getting into your brokerage account, etc- you can find yourself holding a stock that is getting delisted or RS’d on you. You went on vacation and open your brokerage account a week or two later to see you’re down like 25-90%. People can always do day trades on them, but the potential of a swing trade turning against you is high when you don’t know ll the ins and outs of when an announcement or decision is made. You think compliance window still has plenty of time, and then get caught off guard by the shareholder vote. Or you think a catalyst will send it to the moon and the catalyst is delayed or comes on a really bad macro day. Look at MDAI FDA approval. Got approved over weekend and then next trading day was luke warm at best. Hopium really can kill your trades. The delisting threat just adds more stress until you cut your losses or a miracle happens.

magicjohnson89

I was 65% up on MDAI. Averaged up and now I’m 40% down. Sigh.

Consistent_Panda5891

7$ price target on yahoo... Seems a candy when is below 9$ as was today, but yeah current price is tough to break until volume arrives... Specially on negative macro day. 🥭 puts have to print, and will print relentless market does, if it goes green he says 🍅 and easy peasy lemons squizy. I am fine holding SPY puts, maybe roll to Nasdaq calls later today if SPY gets around 722 again, quitting if we see 733 breakout or no further downside. As spaceX should boom it. Btw of low market cap multibaggers you could take a look to MDAI, I am pretty invested there, and want slightly more drop to average down or just upside to make $ 😂. Current price for week is disgusting all days the same +-3.75% movement. Still only 8% short volume which is Hudson Bay hedge mainly to keep warrants out of the money, that's the reason current price has...

Fit_Canary_7196

I asked the same question: “Today looks like a broad risk-off pullback hitting exactly the kinds of names you’re heavy in: AI infrastructure, speculative biotech, small caps, and momentum growth. The main drivers today appear to be: 1. AI valuation / spending fears 2. Rising concern that the market is too concentrated in tech 3. Profit-taking after a huge AI-led run 4. Oil/geopolitical pressure and rate sensitivity 5. Weak breadth under the surface A major catalyst was Alphabet announcing an enormous $80B equity raise to fund AI infrastructure expansion. Markets interpreted that as: * AI is becoming massively capital intensive * dilution risk is real * even the giants need huge funding now That spooked the entire AI ecosystem. At the same time, analysts are warning the market has become dangerously dependent on a handful of AI leaders. Reuters noted tech now represents over 39% of the S&P 500 market cap — above dot-com era concentration levels. That matters for you specifically because many of your holdings sit in: * AI semis * AI infrastructure * robotics * speculative biotech * high-beta growth * moonshots Those sectors tend to get hit hardest when: * yields rise * oil spikes * AI sentiment cools * institutions reduce risk exposure So holdings like: * NVIDIA * Micron Technology * Himax Technologies * Recursion Pharmaceuticals * SLS * MDAI * AST SpaceMobile * Rocket Lab * Symbotic …can easily fall 5–15% in a normal “AI unwind” day even without company-specific bad news. What’s important: This does NOT currently look like a systemic collapse day. It looks more like: * rotation * de-risking * valuation compression * momentum unwinding”

Consistent_Panda5891

I am having a good chill 5% day in MDAI. Thanks Hudson Bay, easy forever till 2028 or short squeeze 2-2.85$ to avoid warrants exercising for the rest but yes allowing for them. Nevertheless business monopoly is strong for that stock being 5$ within 2 years

OverDisplay6408

# $MDAI  [https://www.tradeapes.com/s/2ce9179d-e5d4-4de4-a452-0d57ccef804f/MDAI](https://www.tradeapes.com/s/2ce9179d-e5d4-4de4-a452-0d57ccef804f/MDAI)

magicjohnson89

Yeah. Completely fumbled MDAI. Got caught up in the pump, sold some other stuff and put more money in, raised my buy price and got obliterated at market open. Sold what I'd put in and bought back what I had. So. I lost all my profit for the year and a further 1k, AND I have less shares in all my holdings than previously. What a total fucking idiot.

magicjohnson89

Lol so after my ban for wishing death on RBNE I may add MDAI to the list.

phantom-menace212

The fact that the FDA’s General & Plastic Surgery Advisory Committee reviewed this and granted clearance is the highest-credibility validation possible. The committee included burn surgeons who would have immediately spotted the “pixels vs. wound sites” critique if it were a real issue. The critiques mentioned from the other Redditor are mostly misinformed points covered in decorated vocab. What you actually need to worry about as an MDAI investor: \- Skin tone bias in optical imaging is real but that’s an industry wide concern not just for MDAI \- Hospital Adoption is not a guarantee but we have BARDA help to push out at least 30 units so that’s an insane boost for the company \- Hudson Bay needs to sell their warrants and stop surpassing the stock (expected to be done by late 2026) so stock price can confidently go above 2.51

Tim0281

Short term buyers in the MDAI subreddit are panicking. As much as I'd love to get the short-term profit, I went into the stock expecting it to be a mid- to long-term investment. It has the added bonus of sending supporting a good product!

Dangerous-Visual-614

MDAI for a short? It's up 106% over the last 3 months. The chart just does not support a short.

LostMyBlueAlien

Love everything about MDAI - the leadership, the product, the solution it is solving - it just makes sense. In it for the long run! My biggest worry was FDA clearance now I can just let it run. Already added more this morning as I still think it is discounted.

BeginningRoad1661

Are they waiting til 8am to release the PR and run MDAI?

anon999976

MDAI coming back down… never trust a biopharma PM pump

StuffedArmadildo

Why is MDAI falling?

StuffedArmadildo

Bought the dip on ENSI and GCTS and hoping for some steady climbing again after Friday. Main play for today is MDAI, good news, hasn't had a huge pump compared to some stocks today, hoping for it to hold till market open.

magicjohnson89

Look at all these fake bio stocks, pumping and dumping on no news or rumours. Hundreds of percent. And my beloved MDAI, FDA approval, a product that makes a damn difference, popping 25%. DISGUSTING. (Don't @ me with 125% up over the past 3 months, not interested)

magicjohnson89

Is MDAI how I make my losses back? Pray for me lads. PRAY FOR ME. Price target is \*checks notes\* $12 to break even.

Low_Court_6648

MDAI got FDA approval this weekend

BostonbRamen

I can see how this can be confusing. That is when the FDA stamped it. Doesn't mean Spectral got word yet. Additionally none of us caught it around Thursday or Friday, from the data we have it was publicly sent out on the system's Saturday refresh. We picked it up from closely watching the FDA De Novo database, which is publicly accessible. If Spectral did get notice, it was a holiday weekend in the US. Management very likely would have held the press release as it wouldn't be good to release on a Friday when headed into a holiday weekend as the markets were closed on Monday for the holiday. Releasing the PR notice during premarket or at open on Tuesday is likely what we'll see. Should be an exciting day for MDAI! 😄

BeginningRoad1661

MDAI and what else

Beowein

$MDAI this week. FDA approval for their DeepView system came in last week, kind of under the radar. Obligatory do your own due diligence. Here is some DD I wrote up on it awhile back (I got in around 1.51 per share): Spectral AI (MDAI) uses multispectral imaging (MSI) to see beMDAIneath the surface of the skin to provide clinicians with an objective, binary prediction of wound healing potential on day one of the injury. Current standard of care relies on the naked eye. Clinical studies have repeatedly shown that even experienced burn specialists are only about 60-70% accurate in assessing burn depth on the first day of injury. Because they cannot be sure, surgeons wait. They apply dressings and observe the wound for 14-21 days. This waiting period incurs massive costs (hospital bed days at \~$3,000-$5,000/day), increases infection risk (sepsis), and delays patient return to work\*\*.\*\* MDAI's DeepView provides a >80% accurate assessment on day one, allowing for immediate excision and grafting of non-healing tissue, or immediate discharge of healing tissue. MDAI does not use Generative AI (like GPT) which creates new data based on probabilistic patterns. Instead, it uses Discriminative AI, which classifies existing data into binary categories (Heal vs. Non-Heal). The "moat" around this AI is the training data. Spectral AI has spent over a decade curating a proprietary clinical database containing over 340 billion clinically validated data points. This database links specific spectral signatures to ground-truth clinical outcomes (i.e., did the wound actually heal 21 days later?).  A competitor cannot simply buy a hyperspectral camera and replicate DeepView. They would need to conduct years of longitudinal clinical trials to replicate the training dataset. This "data moat" is the most valuable asset on the balance sheet, virtually impossible to value using standard book metrics. MDAI holds 12 US patents and 14 international patents. The central catalyst for the MDAI investment thesis is the pending FDA decision. They applied for De Novo review in June 2025. The FDA's De Novo review timeline is usually around 150 days, but reviews of AI devices have been seen to extend to 9-12 months, which puts the decision somewhere between Q1 and early Q2 2026. This decision looks to be the catalyst.

Smooth-Limit-1712

Oh hell yeah, that's awesome news for MDAI! FDA approval for a device like that is a game changer, especially with government and military applications. Big congrats on riding that one out. Really looking forward to seeing how that company unfolds.

Low_Court_6648

MDAI is the only play this coming week. FDA APPROVAL this weekend.

HeadfirstDuck

Entering MDAI as much as I can under $4

CryanRohen

MDAI just got FDA approval apparently. Could pop off on Tuesday

CovertMidget

MDAI is going to get the commercialization ball rolling hard and fast, they already have a back log from the ABA burn conference of device placements after FDA approval from all the burn specialists that visited them. And the additional 30, then another 140 devices being procured by BARDA themselves. There are additionally so many hospital partnerships already, it’ll start spreading fast. I see this being a $20 in a year if the commercialization vision is expressed well

magicjohnson89

MDAI got FDA approval. Fucking boom.

endwithel

I done exactly the same. Perhaps we are wrong, but today I left only MDAI and DRTS in my port + shorted NVTS at 29.37. For me short means selling shares not options..

AfternoonEfficient

Holding MDAI for shure

Dry-Low-1446

MDAI

magicjohnson89

MDAI really is ramping up...are we getting closer to FDA?

CovertMidget

$MDAI is 90% of my portfolio and is up from a 50% allocation back in late summer 2024. I fully believe in FDA approval by end of June and a risk-on retaking of the stock to $4-5 minimum. FDA approval of their De Novo application sets the groundwork their entire commercial future both in the US and globally, both the burn indication and the range of additional indications in the pipeline like wound measurement tech, diabetic foot ulcer closing prediction, critical limb ischemia prediction, and more.

Classic-Session-5551

My issue with them after skimming is TAM. Upside seems capped as skin is one of the easiest and lowest cost organs to harvest so even if it works perfectly the value of the device itself might not outweigh the costs of the device, as opposed to traditional channels. Or rather, not by much, nor for many people.  Since some have drawn comps to MDAI they should know the DFU expansion for MDAI is their upside, not burns. Which you might be surprised to find is a far, far larger market. They also address every single burn case, essentially, as opposed to a minority of them - and seem to have meaningfully better improvement rates for outcomes, if the site data is to be believed. Also 70-80M entry vs 140M entry.  And they also aren't drowning in debt with 46M on notes alone and rising, as offset by their... still failing to be profitable and operating at heavy (nearly 10M per quarter)* losses despite getting their initial FDA approvals back in 2018, with most recent expanded device approvals still 2 years back in 2024. And no, they don't have a solid tangible asset base offsetting either. This isn't just dilution risk, it's in the realm where they could feasibly exhaust all credit lines if they don't start to turn a profit in the next couple of years. Which there's no indication whatsoever they will - that I've seen so far.  I'd encourage anyone to fact check for themselves, like I said I skimmed a 1 hour review. And at 5AM. But looks like shit from this. Going to study it in depth tomorrow and I expect I'll run the numbers for a short if anything.  *EBIT

Classic-Session-5551

Better ask, what's the similarity. This is a (purportedly) better tech for skin grafts. MDAI is diagnostics. 

Ok_Understanding_966

What is the difference with MDAI?

magicjohnson89

MDAI performing amazing today given the market…

PristineDiscount3208

MDAI fits your bill. Using AI to assist burn patterns and such.

magicjohnson89

I'm deep in MDAI and EVTL. Speculative yes, gambling no. These both seem solid and cool as fuck.

Low_Court_6648

MDAI

Delicious-Manager613

MDAI

Low_Court_6648

More MDAI

ObligationMain6488

MDAI, medical device(s) that run on AI. Should be getting FDA approval in the next few months for flagship product

Kraken357

I'm watching MDAI (Spectral AI) closely. FDA approval expected within next 1-1.5 months for burn wound AI imaging tool. Gov-backed/BARDA-funded. The DeepView system, which they are anticipating getting FDA approval for shortly, is the system designed for the hospital setting. DeepView Snapshot M is a rugged handheld unit for battlefield triage. I see this as a great health/military AI play.

Low_Court_6648

MDAI

Delicious-Manager613

MDAI next

Low_Court_6648

MDAI

ObiWanKenBlowMeIn123

On MDAI as well, let's hope it continues rising.

CovertMidget

$MDAI continuing its bull run to FDA approval even through market weakness and average volume. I’m excited for when some real volume gets on this thing upon approval. This system is Breakthough Device Designated with multiple pre-submission meetings. Guidance is for approval by Q2 2026, only two months to go!

RetailEdge

I use ChatGPT as a screener. For example, I'll ask it to generate a list of publicly traded companies under $1B market cap within the specific industries I want to invest in with a brief description. Which for me is usually tech or consumer products; those are the areas that I feel the most confident identifying successful prospects. If the initial description sounds like something that has a lot of potential, then all of the research I described previously begins. I'll also occasionally look through Reddit for leads. Sometimes it's something I see in my day to day life. Watching the documentary 'Wild Wild Space' got me interested in investing in satellite imagery; looking for an earlier stage alternative to Planet Labs lead me to SATL. I saw how quickly the drone industry is expanding and wanted to find an investment in either drone manufacturing or a product utilized by drones. That brought me to PRZO. I also wanted to invest in biotech. The products that looked the most promising to me ended up being made by HYPR, MDAI and AIMD. After seeing how quickly the robotaxi industry was expanding, I decided I wanted to invest in autonomous vehicles. That eventually lead me to AUR. Basically, I'm constantly keeping an eye out for emerging markets and then try to find companies within them that have a product I believe in.

ObiWanKenBlowMeIn123

Thanks for putting both on my radar, I've been in since I've read your DD on them! Just picking your brain here, as you seen quite knowledgeable about the biotech space: what are your thoughts (if you have them and are willing to part with them) on MDAI and SLS? Have a stake on both too, but I don't see them much here aside from the odd mention 👀

magicjohnson89

So I canned MIGI because I cannot be fucking arsed with this up down daily bullshit from your orange nazi leader. 50/50 (£5k lol) split of MDAI and EVTL. Happy with that.

CorkNZ2021

ATCH turning the corner right now. DFLI beginning pivot from RV battery to trucking fleet APUs and off grid rail. DVLT starting to lock in tokenisation revenue. MDAI getting very close to stage 3 with FDA for their AI burn diagnostic tech . I know I know heard it all before with pharmaceuticals but this one is different as funding coming from govt (BARDA) which includes the funding to rollout after FDA approval.

_DoubleBubbler_

Well don’t beat yourself up about it as we’ve all been there. And as you say, profit is profit! I am not looking at anything new currently but my current DB selection is ENSI/ENSIF, EVTL, IES/IESVF, LUNR, MDAI, SESG and RDDT. Those are my more adventurous investments and I spread risk with some index trackers and income stocks amongst other things.

magicjohnson89

MDAI just announced an 8m share dilution. FUCK.

magicjohnson89

MDAI. Double Bubbler has some good DD on it.

Bluebird-9641

OMEX, MDAI, PRQR, SOAR, HGRAF, VWAV These are on my watchlist, the last two are past penny stock range but still cheap [5.49, 6.89], are any of you watching these and if so which do you have the most conviction in and why?

CovertMidget

$MDAI is breaking out and will return +50% or more in the next couple of months if the past two breakout patterns apply this time. I just bought 2000 more shares at $1.95 and apparently so did a few people

Smooth-Limit-1712

Wow, that's some serious DD you've put together on $MDAI! Really appreciate the depth of your research and breaking down the catalyst potential. You've clearly been following this one closely. Hope it pays off big for you, man. Always good to see folks sharing this level of conviction.

Resident-Car-6648

MDAI

EmbarrassedPart1256

I read “check cash” quickly today when glancing at $MDAI & thought “that makes sense” with the shape of the economy… Now if someone can find me an *actual* check-cashing penny stock I’ll pay you.

BuyingHighSellingLo

MDAI i’m buying every chance i get

BuyingHighSellingLo

MDAI, just in time for the hopeful FDA approval. I reccomend you checking it out!

Stitch426

MDAI up 15% on no news. Hmmm

Low_Court_6648

MDAI, maybe FDA approval i getting closer🤞🏻

CovertMidget

$MDAI is having an unusual strong and steady momentum buying day on no explicit news. Since FDA decision is anticipated by the end of Q2, this is feeling like someone knows something…

CovertMidget

$MDAI is about to be first mover to the AI diagnostic triaging market with FDA approval of their DeepView system by June this year which will determine on Day 1 of injury where surgical intervention is necessary (compared to Day 21, the current standard of care). They forecast $24,000 average savings per hospitalized burn patient, of which there are 40,000 in the US alone. This represents ~$1B of yearly savings just for US hospitalized burn patients, not accounting for the rest of the 500,000 Americans that visit hospitals for burns every year. If Spectral AI captures just some of that as revenue, they’ll be huge. They just got extended $31 million in BARDA funding for commercialization in anticipation of the FDA decision, all that’s left is for the FDA to say yes.

gosumage

MDAI to the Moon :)

Accomplished_Note535

MDAI?

backtotheland76

MDAI steadily building in recent days

ZZerozen

Medtech : $ALCJ $MDAI

Reasonable_Water6232

Is it me or is the premarket pretty dead ? Maybe orange man should same something so it would move something :D PS! Only in MDAI.

Low_Court_6648

MDAI, Q4 tonight

Low_Court_6648

MDAI

Low_Court_6648

MDAI

magicjohnson89

I'm coming to terms with the fact I've been scammed and that I won't get my £12k back. So do I pull my remaining 10k out on Monday, thinking of just dumping it all in MDAI. Been watching it for the last 6 months.

Low_Court_6648

MDAI

Low_Court_6648

Also MDAI

Reasonable_Water6232

I am in MDAI. Been holding for few days. Seems to be going up slowly  🐌.  They've got post market earnings on 24th. If good news, will go even higher.

Green_Bumblebee1848

$MDAI moving again

backtotheland76

Up next, MDAI. Chart is looking great and volume is way up

Any_Pomegranate1134

CYCU Current price around $1.21 (down ~2.42% recently), with normal/low volume and a tiny market cap of ~$5M. No major recent news or catalysts on the page—appears quiet with no clear driver for movement beyond general market or low-float volatility typical for micro-caps. DVLT Current price around $0.80 (down ~14.3% on heavy volume of 113M+ shares vs. avg ~72M), market cap ~$463M. What's moving it: Recent Q4 2025 earnings showed the first profitable quarter, record revenue growth, and a reiterated $200M revenue target for 2026 (~400% YoY growth). It also announced a definitive agreement to acquire NYIAX (AI-driven data monetization + institutional infrastructure) MDAI Current price around $1.42 (up +18.33% with massive volume spike of ~7M shares vs. avg ~414K), market cap ~$43.6M. What's moving it: Strong catalyst from a $31.7M BARDA (U.S. government) funding award to accelerate DeepView System development. Other notes include upcoming Q4 2025 earnings, a new CEO appointment, and participation in National Burn Awareness Week. The funding news is clearly driving the surge and volume. CJMB NOTHING MUCH HERE … group chat driven stock discord , Reddit . I stand Corrected here PROP (Prairie Operating Co.) Current price around $1.57–$1.63 (modest +1–2% moves recently), market cap ~$90–118M. What's moving it: No major breaking news today, but upcoming catalysts include senior management attending the ROTH Conference (March 22–24, 2026) and Q4/full-year 2025 financial results release (after close on March 31, 2026). Moves appear tied to broader energy sector sentiment, conference anticipation, or low-float trading rather than a specific event. OPTT Current price around $0.36 (small +1.7% or volatile moves), market cap ~$82M. Recent quarterly revenue was down (to ~$513K) with ongoing losses. What's moving it: Recent volatility includes reports of the stock more than doubling after a "leading" energy company commissioned a feasibility study (specific catalyst for a prior surge). Broader moves stem from its penny-stock nature, marine/energy sector news, or contract potential, despite weak recent earnings. Volume can spike on any development.